Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response: Harnessing Lessons from the Efforts to Mitigate the COVID-19 Pandemic

Global Perspectives on Vaccine Distribution Logistics for Influenza Preparedness (Day 3)

May 21, 2021

11:25 AM - 1:30 PM (ET)

Past

Agenda

About

During the third meeting, the committee will discuss various logistical and on the ground needs for vaccine distribution and product stockpiling and its applicability for influenza. Experts in areas of global investment and regional logistics coordination will provide perspectives on sustainable development of the vaccine ecosystem. The committee will discuss existing structures and gaps in the supply chain as related to influenza preparedness.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

• Ravi Anupindi
• Prashant Yadav
• Matthew Downham
• Jennifer Pancorbo
• Mahshid Abir
• Noreen Hynes
• Pinar Keskinocak
• Saad Omer
• William Burel
• Rick Bright
• David Kaslow
• Nagwa Hasanin

The following topics were discussed in the closed sessions:

• Overview of Meeting Goals
• Discussion of Key Questions for Speakers
• Speaker Session Debrief

Date of posting of Closed Session Summary:

May 21, 2021

Organizing Project

Addressing Issues of Vaccine Distribution and Supply Chains to Advance Pandemic and Seasonal Influenza Preparedness and Response

Contact

Contact us

InfluenzaPreparednessSupply@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Global Perspectives on Vaccine Distribution Logistics for Influenza Preparedness (Day 2)

May 14, 2021

9:30 AM - 10:05 AM (ET)

Past

Agenda

Download the Agenda

About

During the third meeting, the committee will discuss various logistical and on the ground needs for vaccine distribution and product stockpiling and its applicability for influenza. Experts in areas of global investment and regional logistics coordination will provide perspectives on sustainable development of the vaccine ecosystem. The committee will discuss existing structures and gaps in the supply chain as related to influenza preparedness.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

• Ravi Anupindi
• Prashant Yadav
• Mahshid Abir
• Saad Omer
• Jennifer Pancorbo
• Noreen Hynes
• David Kaslow
• Nagwa Hasanin
• Pinar Keskinocak
• Rick Bright

The following topics were discussed in the closed sessions:

• Overview of Meeting Goals
• Discussion of Key Questions for Speakers
• Speaker Session Debrief
• Discuss Findings, Conclusions, and Recommendations in Working
Groups
• Share Cross-Cutting Recommendations

Date of posting of Closed Session Summary:

May 18, 2021

Organizing Project

Addressing Issues of Vaccine Distribution and Supply Chains to Advance Pandemic and Seasonal Influenza Preparedness and Response

Contact

Contact us

InfluenzaPreparednessSupply@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting Closed

Designing Global Coordination Structures for Influenza (Meeting 3, Day 3)

May 14, 2021

8:00 AM - 11:00 AM (ET)

Past

About

During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first two days of the meeting, each of these working groups will have targeted speaker sessions, to allow them to ask specific questions about governance and financing structures that may address influenza and respiratory pathogen vaccine barriers globally. During the final day of the meeting, working groups will come together to share their findings and conclusions and begin to form study recommendations.

WATCH THE WEBINAR

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

Peter Sands
Devi Sridhar
William Ampofo
Phyllis Arthur
Christopher T. Bauch
Keiji Fukuda
Bruce G. Gellin
Amanda L. Glassman
Richard J. Hatchett
Charles O. Pannenborg (OK)
Alexandra Phelan
Christopher Snyder
Charlotte L. Weller (Charlie)

The following topics were discussed in the closed sessions:

1) Working Group Break-out Sessions
2) Committee Discussion of Recommendations & Report Structure
3) Forming Conclusions and Recommendations at NASEM

Organizing Project

Global Coordination, Partnerships, and Financing Recommendations for Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response

Contact

Contact us

GlobalCoordinationInfluenza@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Webcast

Global Perspectives on Vaccine Distribution Logistics for Influenza Preparedness (Day 1)

May 12, 2021

9:30 AM - 11:15 AM (ET)

Past

Agenda

Download the Agenda

About

During the third meeting, the committee will discuss various logistical and on the ground needs for vaccine distribution and product stockpiling and its applicability for influenza. Experts in areas of global investment and regional logistics coordination will provide perspectives on sustainable development of the vaccine ecosystem. The committee will discuss existing structures and gaps in the supply chain as related to influenza preparedness.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

• Ravi Anupindi
• Prashant Yadav
• Noreen Hynes
• Jennifer Pancorbo
• Greg Burel
• Saad Omer
• Nagwa Hasanin
• Pinar Keskinocak
• Mahshid Abir
• David Kaslow
• Matthew Downham

The following topics were discussed in the closed sessions:

• Overview of Meeting Goals and Objectives
• Discussion of Key Questions for Speakers
• Speaker Session Debrief
• Study Updates

Date of posting of Closed Session Summary:

May 18, 2021

Organizing Project

Addressing Issues of Vaccine Distribution and Supply Chains to Advance Pandemic and Seasonal Influenza Preparedness and Response

Contact

Contact us

InfluenzaPreparednessSupply@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Webcast

Priorities for Clinical Development of Vaccines for Influenza Preparedness

May 12, 2021

8:00 AM - 11:00 AM (ET)

Past

Agenda

Download the Agenda

About

The COVID-19 pandemic has facilitated rapid advancement of platform technologies for vaccine development. During this meeting, the committee will discuss the ways in which lessons from the clinical development of the COVID-19 vaccine can be leveraged to improve influenza vaccine research and development. The session will apply previous discussions about best practices in clinical science and emerging technologies to fit a global context as it pertains to seasonal, pandemic and universal influenza.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

• Enriqueta Bond
• Kanta Subbarao
• Annette Fox
• Maria Elena Bottazzi
• Rebecca Cox
• Florian Krammer
• Grace Lee
• Joshua Sharfstein

The following topics were discussed in the closed sessions:

• Debrief of Speaker presentations
• Structure of Feature Meetings
• Next Steps

The following materials (written documents) were made available to the committee in the closed sessions:

Briefing Book

Date of posting of Closed Session Summary:

May 17, 2021

Organizing Project

Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response

Contact

Contact us

FluPreparednessStudyRD@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting

Lessons Learned from Global Influenza Technology Transfer Partnerships – Meeting 3, Supplementary Session

May 11, 2021

1:00 PM - 1:45 PM (ET)

Past

Agenda

Download the Agenda

About

In this short open session, the committee’s technology and manufacturing partnerships working group will hold a Question and Answer session with a speaker about lessons learned from the World Health Organization (WHO) Global Action Plan for Influenza Vaccines (GAP) and the Biomedical Advanced Research and Development Authority (BARDA)’s collaborations for distributed influenza vaccine technology transfer. The goal of the session is to better understand how the International Influenza Vaccine Technology Manufacturing Capacity program responded to the H1N1 pandemic (2009), and the ways in which the partnership was successful.

Additional Information

Is it a Closed Session event?

Not Closed

Organizing Project

Global Coordination, Partnerships, and Financing Recommendations for Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response

Contact

Contact us

GlobalCoordinationInfluenza@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting

Designing Global Coordination Structures for Influenza - Technology and Manufacturing Working Group (Meeting 3, Day 2)

May 7, 2021

9:00 AM - 11:00 AM (ET)

Past

Agenda

Download the Agenda

About

During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first two days of the meeting, each of these working groups will have targeted speaker sessions, to allow them to ask specific questions about governance and financing structures that may address influenza and respiratory pathogen vaccine barriers globally. During the final day of the meeting, working groups will come together to share their findings and conclusions and begin to form study recommendations.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

William Ampofo
Phyllis Arthur
Bruce G. Gellin
Richard J. Hatchett
Charlotte L. Weller (Charlie)

The following topics were discussed in the closed sessions:

1) Speaker Presentation
2) Discuss findings/conclusions/recommendations

Organizing Project

Global Coordination, Partnerships, and Financing Recommendations for Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response

Contact

Contact us

GlobalCoordinationInfluenza@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting

Designing Global Coordination Structures for Influenza (Meeting 3, Day 2)

May 7, 2021

9:00 AM - 11:00 AM (ET)

Past

Agenda

Download the Agenda

About

During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first two days of the meeting, each of these working groups will have targeted speaker sessions, to allow them to ask specific questions about governance and financing structures that may address influenza and respiratory pathogen vaccine barriers globally. During the final day of the meeting, working groups will come together to share their findings and conclusions and begin to form study recommendations.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

Peter Sands
Christopher T. Bauch
Christopher Snyder
Amanda L. Glassman
Charles O. Pannenborg (OK)

The following topics were discussed in the closed sessions:

1) Speaker presentations
2) Discuss findings/conclusions/recommendations

Organizing Project

Global Coordination, Partnerships, and Financing Recommendations for Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response

Contact

Contact us

GlobalCoordinationInfluenza@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting

Designing Global Coordination Structures for Influenza - Pathogen Sharing Working Group (Meeting 3, Day 2)

May 7, 2021

9:00 AM - 11:00 AM (ET)

Past

Agenda

Download the Agenda

About

During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first two days of the meeting, each of these working groups will have targeted speaker sessions, to allow them to ask specific questions about governance and financing structures that may address influenza and respiratory pathogen vaccine barriers globally. During the final day of the meeting, working groups will come together to share their findings and conclusions and begin to form study recommendations.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

Devi Sridhar
Keiji Fukuda
Alexandra Phelan

The following topics were discussed in the closed sessions:

1) Speaker Presentations
2) Discuss findings/conclusions/recommendations

Organizing Project

Global Coordination, Partnerships, and Financing Recommendations for Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response

Contact

Contact us

GlobalCoordinationInfluenza@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting Closed

Designing Global Coordination Structures for Influenza - Pathogen Sharing Working Group (Meeting 3, Day 1)

May 6, 2021

8:00 AM - 10:00 AM (ET)

Past

About

During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first two days of the meeting, each of these working groups will have targeted speaker sessions, to allow them to ask specific questions about governance and financing structures that may address influenza and respiratory pathogen vaccine barriers globally. During the final day of the meeting, working groups will come together to share their findings and conclusions and begin to form study recommendations.

WATCH THE VIDEO RECORDING

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

Gian-Luca Burci
Keiji Fukuda
Alexandra Phelan

The following topics were discussed in the closed sessions:

Delineate areas for working group recommendations

Organizing Project

Global Coordination, Partnerships, and Financing Recommendations for Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response

Contact

Contact us

GlobalCoordinationInfluenza@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting

Designing Global Coordination Structures for Influenza - Technology and Manufacturing Working Group (Meeting 3, Day 1)

May 6, 2021

8:00 AM - 10:00 AM (ET)

Past

Agenda

Download the Agenda

About

During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first two days of the meeting, each of these working groups will have targeted speaker sessions, to allow them to ask specific questions about governance and financing structures that may address influenza and respiratory pathogen vaccine barriers globally. During the final day of the meeting, working groups will come together to share their findings and conclusions and begin to form study recommendations.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

Phyllis Arthur
Bruce G. Gellin
Richard J. Hatchett
Charlotte L. Weller (Charlie)

The following topics were discussed in the closed sessions:

1) Speaker Presentation
2) Delineate areas for working group recommendations

Organizing Project

Global Coordination, Partnerships, and Financing Recommendations for Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response

Contact

Contact us

GlobalCoordinationInfluenza@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Meeting Closed

Designing Global Coordination Structures for Influenza - Vaccine Access and Financing Working Group (Meeting 3, Day 1)

May 6, 2021

8:00 AM - 10:00 AM (ET)

Past

About

During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first two days of the meeting, each of these working groups will have targeted speaker sessions, to allow them to ask specific questions about governance and financing structures that may address influenza and respiratory pathogen vaccine barriers globally. During the final day of the meeting, working groups will come together to share their findings and conclusions and begin to form study recommendations.

WATCH THE VIDEO RECORDING

Additional Information

Is it a Closed Session event?

Institution Closed

The following committee members were present at the closed sessions of the event

Peter Sands
Christopher T. Bauch
Christopher Snyder
Amanda L. Glassman
Charles O. Pannenborg

The following topics were discussed in the closed sessions:

Delineate areas for working group recommendations

Organizing Project

Global Coordination, Partnerships, and Financing Recommendations for Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response

Contact

Contact us

GlobalCoordinationInfluenza@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Webcast

Clinical Development of Vaccine Platforms for Influenza Preparedness

April 28, 2021

3:00 PM - 4:30 PM (ET)

Past

Agenda

Download the Agenda

About

The COVID-19 pandemic has facilitated rapid advancement of platform technologies for vaccine development. During this meeting, the committee will discuss the ways in which lessons from the clinical development of the COVID-19 vaccine can be leveraged to improve influenza vaccine research and development. Speakers will address topics such as best practices in clinical vaccine research, lessons from COVID-19, innovative trial design approaches and R&D capacity in various settings. These discussions will also consider feasibility in terms of policy and regulatory approval mechanisms.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

• Enriqueta Bond
• Kanta Subbarao
• Maria Elena Bottazzi
• Annette Fox
• Florian Krammer
• Grace Lee
• Milagritos Tapia
• Joshua Sharfstein

The following topics were discussed in the closed sessions:

• Review of Report Timeline and agendas for upcoming meetings
• Discussion of key findings, conclusions, recommendations and gaps

The following materials (written documents) were made available to the committee in the closed sessions:

Briefing Book

Organizing Project

Vaccine Research and Development Recommendations for Advancing Pandemic and Seasonal Influenza Preparedness and Response

Contact

Contact us

FluPreparednessStudyRD@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Webcast

Exploring Influenza Vaccine Critical Inputs, Technologies, and Logistics (Day 2)

April 27, 2021

11:30 AM - 12:30 PM (ET)

Past

Agenda

Download the Agenda

About

During this second meeting, the committee will address various factors that facilitate the scale-up of influenza vaccine manufacturing and distribution. Speakers will address global supply chain logistics, technological advancements, and critical inputs needed for production. Sessions will review guidance and apply lessons learned from previous pandemics, including COVID-19.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

4/27
• Ravi Anupindi
• Pinar Keskinocak
• Nagwa Hasanin
• David Kaslow
• Matthew Downham
• Jennifer Pancorbo
• Norreen Hynes
• Saad Omer
• Prashant Yadav

4/30
• Ravi Anupindi
• David Kaslow
• Jennifer Pancorbo
• Mahshid Abir
• Nagwa Hasanin
• Noreen Hynes
• Pinar Keskinocak
• Prashant Yadav
• Matthew Downham
• Saad Omer

The following topics were discussed in the closed sessions:

4/27
• Overview of Meeting Goals
• Discussion of Speaker Sessions
• Begin Brainstorming Recommendations

4/30
• Overview of Meeting Goals
• Overview of Findings, Conclusions, and Recommendations
• Refine Potential Findings, Conclusions, and Recommendations
• Reconvene and Share Feedback

Date of posting of Closed Session Summary:

April 30, 2021

Organizing Project

Addressing Issues of Vaccine Distribution and Supply Chains to Advance Pandemic and Seasonal Influenza Preparedness and Response

Contact

Contact us

InfluenzaPreparednessSupply@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Webcast

Exploring Influenza Vaccine Critical Inputs, Technologies, and Logistics (Day 1)

April 23, 2021

9:30 AM - 12:00 PM (ET)

Past

Agenda

Download the Agenda

About

During this second meeting, the committee will address various factors that facilitate the scale-up of influenza vaccine manufacturing and distribution. Speakers will address global supply chain logistics, technological advancements, and critical inputs needed for production. Sessions will review guidance and apply lessons learned from previous pandemics, including COVID-19.

Additional Information

Is it a Closed Session event?

Partially Closed

The following committee members were present at the closed sessions of the event

• Rick Bright
• Ravi Anupindi
• Noreen Hynes
• Greg Burrel
• Pinar Keskinocak
• Matthew Downham
• Prashant Yadav
• Jennifer Pancorbo
• Mahshid Abir
• Saad Omer
• Nagwa Hasanin

The following topics were discussed in the closed sessions:

• Overview of Meeting Goals and Objectives
• Discussion of Key Questions for Speakers
• Discussion of Speaker Sessions

Date of posting of Closed Session Summary:

April 30, 2021

Organizing Project

Addressing Issues of Vaccine Distribution and Supply Chains to Advance Pandemic and Seasonal Influenza Preparedness and Response

Contact

Contact us

InfluenzaPreparednessSupply@nas.edu

Disclaimer

It is essential to the National Academies mission of providing evidence-based advice that participants in any of our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. The statements and presentations during our meetings or events are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academy of Sciences, which is a non-partisan, tax exempt organization that includes under its Charter the National Academy of Engineering and National Academy of Medicine, and that operates the National Research Council.

Log In

Sign in to access your saved publications, downloads, and email preferences.

Former MyNAP users: You'll need to reset your password on your first login to MyAcademies. Click "Forgot password" below to receive a reset link via email. Having trouble? Visit our FAQ page to contact support.

Members of the National Academy of Sciences, National Academy of Engineering, or National Academy of Medicine should log in through their respective Academy portals.

Email (required)
Password (required)

Don't have an account?

Register

Email (required)
New password (required)
Retype password (required) Password must be at least 8 characters
I accept the terms of use
terms of use

Thank You

Thank you for creating a MyAcademies account!

Enjoy free access to thousands of National Academies' publications, a 10% discount off every purchase, and build your personal library.

Forgot Password

Enter the email address for your MyAcademies (formerly MyNAP) account to receive password reset instructions.

Reset Requested

We sent password reset instructions to your email . Follow the link in that email to create a new password. Didn't receive it? Check your spam folder or contact us for assistance.

Reset Password

New password (required)
Retype password (required) Password must be at least 8 characters

Reset Password

Your password has been reset.

Log In

Verify email

Verify Your Email Address

We sent a verification link to your email. Please check your inbox (and spam folder) and follow the link to verify your email address. If you did not receive the email, you can request a new verification link below

Subscribe

First Name
Last Name
Email (required)
I agree to receive emails from the National Academies (required)

We respect your privacy and will never share your information.

My Academies

Advancing Pandemic and Seasonal Influenza Vaccine Preparedness and Response: Harnessing Lessons from the Efforts to Mitigate the COVID-19 Pandemic

Global Perspectives on Vaccine Distribution Logistics for Influenza Preparedness (Day 3)

Global Perspectives on Vaccine Distribution Logistics for Influenza Preparedness (Day 2)

Designing Global Coordination Structures for Influenza (Meeting 3, Day 3)

Global Perspectives on Vaccine Distribution Logistics for Influenza Preparedness (Day 1)

Priorities for Clinical Development of Vaccines for Influenza Preparedness

Lessons Learned from Global Influenza Technology Transfer Partnerships – Meeting 3, Supplementary Session

Designing Global Coordination Structures for Influenza - Technology and Manufacturing Working Group (Meeting 3, Day 2)

Designing Global Coordination Structures for Influenza (Meeting 3, Day 2)

Designing Global Coordination Structures for Influenza - Pathogen Sharing Working Group (Meeting 3, Day 2)

Designing Global Coordination Structures for Influenza - Pathogen Sharing Working Group (Meeting 3, Day 1)

Designing Global Coordination Structures for Influenza - Technology and Manufacturing Working Group (Meeting 3, Day 1)

Designing Global Coordination Structures for Influenza - Vaccine Access and Financing Working Group (Meeting 3, Day 1)

Clinical Development of Vaccine Platforms for Influenza Preparedness

Exploring Influenza Vaccine Critical Inputs, Technologies, and Logistics (Day 2)

Exploring Influenza Vaccine Critical Inputs, Technologies, and Logistics (Day 1)